Opthea Ltd
Company Profile
Business description
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
Contact
650 Chapel Street
Level 4, Suite 0403
South Yarra VIC 3141
AUST: +61 398260399
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
34
Stocks News & Analysis
stocks
How not to allocate capital
stocks
This undervalued ASX share just had a moat downgrade
stocks
This ASX share has been awarded a moat by our analysts
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,361.20 | 20.10 | 0.24% |
| CAC 40 | 7,487.42 | 37.98 | 0.51% |
| DAX 40 | 18,726.08 | 92.97 | 0.50% |
| Dow JONES (US) | 41,612.65 | 9.43 | -0.02% |
| FTSE 100 | 8,309.86 | 31.42 | 0.38% |
| HKSE | 17,660.02 | 237.90 | 1.37% |
| NASDAQ | 17,629.29 | 37.17 | 0.21% |
| Nikkei 225 | 36,203.22 | 378.54 | -1.03% |
| NZX 50 Index | 12,671.95 | 32.44 | -0.26% |
| S&P 500 | 5,634.40 | 1.31 | 0.02% |
| S&P/ASX 200 | 8,140.90 | 19.30 | 0.24% |
| SSE Composite Index | 2,704.09 | 13.03 | -0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Telstra Group Ltd TLS | 4.02 | 0.01 | 0.25% |
| Resolute Mining Ltd RSG | 0.72 | 0.01 | -0.69% |
| Imugene Ltd IMU | 0.05 | 0.00 | -4.00% |
| Pilbara Minerals Ltd PLS | 2.85 | 0.03 | -1.04% |
| Red 5 Ltd RED | 0.33 | 0.01 | 1.54% |
| Sayona Mining Ltd SYA | 0.02 | 0.00 | 0.00% |
| Westgold Resources Ltd WGX | 2.67 | 0.09 | -3.26% |
| South32 Ltd S32 | 3.23 | 0.06 | 1.89% |
| Appen Ltd APX | 1.61 | 0.11 | 6.98% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -3.06% |